Pharmacy India

Pharmacy India is your ultimate destination for pharmacy exam preparation and career advancement. Discover top-notch study materials, daily quizzes, and expert courses for pharmacy exams like RRB Pharmacist, GPAT, and NIPER JEE, D.Pharma Exit Exam, etc.

Category: Pharma News

D. Pharm Exit Exam 2024 – जाने क्या pattern हो सकता है |

D. Pharm Exit Exam 2024 – जाने क्या pattern हो सकता है |

डिप्लोमा इन फार्मेसी एग्जिट एग्जामिनेशन (DPEE) का उद्देश्य यह सुनिश्चित करना है कि राज्य फार्मेसी काउंसिल के साथ फार्मासिस्ट के रूप में पंजीकरण के लिए आवेदन करने वाले उम्मीदवार ने फार्मेसी शिक्षा और डिप्लोमा इन फार्मेसी (D.Pharm) पाठ्यक्रम में एक व्यापक व्यावहारिक प्रशिक्षण कार्यक्रम प्राप्त किया है। शिक्षा विनियम, 2020 या विनियम जो फार्मेसी अधिनियम, 1948 की धारा 12 के तहत फार्मेसी काउंसिल ऑफ इंडिया द्वारा अनुमोदित संस्थान में समय-समय पर लागू हो सकते हैं और दवाओं के वितरण और फार्मेसी अभ्यास के अन्य क्षेत्रों में मुख्य दक्षता हासिल कर सकते हैं।

DCGI Sets Common Cold Medication Warnings for Children Under Four Years

DCGI Sets Common Cold Medication Warnings for Children Under Four Years

A significant directive impacting the production and marketing of common cold fixed dosage combinations (FDC) including chlorpheniramine maleate IP 2 mg and phenylephrine HCL IP 5 mg per millilitre drops has been issued by the Drugs Controller General of India (DCGI) in a recent development. Prompted by suggestions from a Subject Expert Committee (SEC) focused on pulmonary issues, the directive requires manufacturers to advise against using this combination in children younger than four years old on the label, package insert, and promotional materials.

Mandatory Exit Test for D. Pharma Students – Dr. Montu M Patel

Mandatory Exit Test for D. Pharma Students – Dr. Montu M Patel

Exciting developments are underway in the pharmaceutical education sector, as plans for a new pharmacy college are set in motion. According to Dr. Montu M Patel, Chairman of the Pharmacy Council of India, it will take approximately a year to establish this groundbreaking institution. The initiative aims not only to meet diverse educational needs but also to address practical requirements within the system.

Urgent Alert: Safety Concerns Surrounding Meftal Spas – The Dangers of Mefenamic Acid Revealed

Urgent Alert: Safety Concerns Surrounding Meftal Spas – The Dangers of Mefenamic Acid Revealed

If you rely on Meftal Spas to alleviate pain, menstrual cramps, or manage rheumatoid arthritis, this news is of paramount importance. The Indian Pharmacopoeia Commission (IPC) has issued a critical drug safety alert, sounding the alarm on Meftal’s active ingredient, mefenamic acid. The alert underscores potential adverse reactions that could lead to a severe condition known as Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) syndrome.

DCC Explores Measures to Address Potential Misuse of Tapentadol and Pregabalin: Regulatory Insights and Recommendations

DCC Explores Measures to Address Potential Misuse of Tapentadol and Pregabalin: Regulatory Insights and Recommendations

The Drugs Consultative Committee (DCC) has recently undertaken a comprehensive examination into the potential misuse of opioid pain-relief medicine tapentadol and the anticonvulsant and analgesic drug pregabalin. This blog post delves into the committee’s decisions and considerations, shedding light on the recommendations for potential control measures on the sales of these drugs in the market.

Opposition Grows Against Proposed NPC Bill 2023: Pharmacy Students Advocate for the Retention of Pharmacy Council of India (PCI)

Opposition Grows Against Proposed NPC Bill 2023: Pharmacy Students Advocate for the Retention of Pharmacy Council of India (PCI)

In a recent development, the Union health ministry’s draft National Pharmacy Commission (NPC) Bill 2023 faces opposition from the Student Pharmacists Rights Committee (SPRC) in Maharashtra. The SPRC has passed a resolution urging the Union government to reconsider its move to create the NPC, emphasizing the importance of retaining the Pharmacy Council of India (PCI).

Ensuring Global Standards: DCC Urged all States to Submit Vaccine Data for WHO Benchmarking

Ensuring Global Standards: DCC Urged all States to Submit Vaccine Data for WHO Benchmarking

In a significant move towards global vaccine quality benchmarks, the Drugs Consultative Committee (DCC) has called upon all Indian states to provide crucial data on vaccine manufacturing and sales. The World Health Organization (WHO) mandates this data for its Global Benchmarking Tool (GBT) assessment, a prerequisite for UN agencies to procure vaccines from Indian manufacturers.

Back to top

Registration Form

Login

This will close in 0 seconds

This will close in 0 seconds

WhatsApp Join Telegram